Target intelligence / Profile preview

Activator protein 1 transcription factor subunit c-Jun (c-Jun)

Target
c-Jun
Molecular classification
Transcription factor, Basic leucine zipper (bZIP) protein, AP-1 complex subunit
01

Overview

Activator protein 1 transcription factor subunit c-Jun (c-Jun) is a DNA-binding protein encoded by the JUN gene and is a central component of the AP-1 (Activator Protein 1) transcription factor complex, often functioning as a heterodimer with c-Fos or other bZIP proteins[1][2][3][7]. c-Jun regulates the transcription of numerous genes involved in critical biological processes including cell cycle progression, apoptosis, proliferation, immune response, and neural repair. It plays a dual role in promoting cell survival/proliferation and protecting against or contributing to cell death depending on cellular context and stimuli, such as stress or cytokines[1][2][3][6][7]. Dysregulation of c-Jun is implicated in various cancers (where it acts as a proto-oncogene), inflammation, neurodegenerative diseases, and tissue injury responses[1][3][5][6][7]. Its transcriptional activity is tightly regulated by phosphorylation, primarily via the stress-activated JNK pathway, making upstream kinases and the AP-1/c-Jun axis a subject of therapeutic research[3][9]. No selective direct c-Jun inhibitors are currently in standard therapeutic use, but it remains a validated target for anti-cancer and anti-inflammatory drug development.

Other names
Jun proto-oncogeneAP-1 transcription factor subunit c-JunJunJUNTranscription factor JunProto-oncogene c-Jun
02

Mechanism of action

Modulation of AP-1-dependent gene transcription (antagonists/inhibitors) Inhibition of c-Jun N-terminal kinase (JNK) pathway to reduce c-Jun phosphorylation and activation[3][9]

03

Biological functions

Regulation of gene transcriptionCell cycle progression (especially G1 phase)Cell proliferationApoptosis (cell death)Cellular response to stress (e.g., UV irradiation)Immune responseCell differentiationNeural development and repair
04

Disease associations

Cancer (proto-oncogene, tumorigenesis)InflammationNeurodegenerative diseaseTissue injury and repair
05

Safety considerations

Targeting c-Jun may impact essential cell proliferation and survival in normal tissues, leading to toxicity.Potential for adverse effects on neural plasticity, repair, immunoregulation, and hepatic function[1][6].Risk of interfering with tissue homeostasis and stress responses.
06

Interacting drugs

There are no widely approved direct small molecule inhibitors in clinical use, but various experimental modulators of c-Jun/AP-1 or upstream kinases (e.g., JNK inhibitors) are studied in preclinical or early clinical research[3][9]. Specific approved drugs are not clearly established from the current literature.
07

Biomarkers

Phosphorylated c-Jun (e.g., Ser63/73) in tumor tissue or inflamed sitesc-Jun expression level as a marker of cellular stress, proliferation, or therapeutic response in cancer and some neurological disorders[3][5][6]

Beyond the preview

Go deeper on Activator protein 1 transcription factor subunit c-Jun (c-Jun).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activator protein 1 transcription factor subunit c-Jun (c-Jun).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call